OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Release Date
2023
(3)
2022
(2)
2015
(2)
2025
(1)
2024
(1)
2021
(1)
2020
(1)
2019
(1)
2016
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Large artery atherosclerotic versus cardioembolism subtypes of large hemispheric infarction in the middle cerebral artery.
Not available
S-EPMC12488826
|
biostudies-literature
Cite
A novel missense KIT mutation causing piebaldism in one Chinese family associated with cafe-au-lait macules and intertriginous freckling.
Not available
S-EPMC4410829
|
biostudies-literature
Cite
Severe Darier's disease patient with mutation of ATP2A2.
Not available
S-EPMC4221357
|
biostudies-literature
Cite
High expression of SPP1 in patients with chronic obstructive pulmonary disease (COPD) is correlated with increased risk of lung cancer.
Not available
S-EPMC8016137
|
biostudies-literature
Cite
Nucleic Acid Vaccine Targeting Nogo-66 Receptor and Paired Immunoglobulin-Like Receptor B as an Immunotherapy Strategy for Spinal Cord Injury in Rats.
Not available
S-EPMC6554366
|
biostudies-literature
Cite
A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China.
Not available
S-EPMC10258179
|
biostudies-literature
Cite
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
Not available
S-EPMC10683300
|
biostudies-literature
Cite
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial.
Not available
S-EPMC9167817
|
biostudies-literature
Cite
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.
Not available
S-EPMC9237056
|
biostudies-literature
Cite
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial.
Not available
S-EPMC9808735
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets